At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
NCT: NCT04393961 · WITHDRAWN
Brief Summary
Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.
Frequently Asked Questions
What is At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study?
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study is a clinical trial registered under NCT04393961. Current status: WITHDRAWN.
What is the status of NCT04393961?
The current status of NCT04393961 (At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study) is: WITHDRAWN.
When did At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study start?
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study started on 2020-04-05.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.